JESSICA PAPPANIKOU: Open Payments
NPI 1033720339 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 15 payments from 9 companies in 2025. Trend: 2023 $99 · 2024 $510 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $218 |
| Incyte Corporation | 2 | $138 |
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| PFIZER INC. | 3 | $61 |
| Stemline Therapeutics Inc. | 1 | $29 |
| Blueprint Medicines Corporation | 1 | $29 |
| Adaptive Biotechnologies Corporation | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
Products named: RYBREVANT, REZUROCK, Monjuvi, ELREXFIO, DARZALEX, ELZONRIS, AYVAKIT, clonoSEQ.
Industry payments across FL — which companies pay providers there.
